Evgen Pharma (GB:TCF) has released an update.
TheraCryf plc, renamed from Evgen Pharma and specialising in oncology and neuropsychiatry drug development, will release its full-year financial results on May 28, 2024. A live presentation hosted by CEO Huw Jones and CFO Toni Hänninen will be accessible via the Investor Meet Company platform, where shareholders can engage and pose questions.
For further insights into GB:TCF stock, check out TipRanks’ Stock Analysis page.
